<<<<<<< HEAD
{"query": "You receive the following question:\nQuestion: What specific criteria were used in the study to define patients with alcohol-use disorder?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 26 subjects without alcohol-use disorder (controls; social drinkers consuming less than 20 g/day), 44 patients with alcohol-use disorder and 88 patients with alcoholic hepatitis. Patients with alcohol-use disorder fulfilling the DSM IV criteria33 of alcohol dependence and with active alcohol consumption (self-reported >60 g/day) presented with various stages of liver disease (21% had advanced F3/4 fibrosis based on fibrosis-4 index) (Supplementary Table 1). Patients with alcohol-use disorder\n", "relevant_passages": ["responses (31). We previously identified Blautia abundance (a genus within class Clostridia) as a predictor of protection from lethal GVHD (12), whereas here we describe Enterococcus domination as a risk factor for GVHD. These two findings are noteworthy in light of our recent observa- tion that a B. producta strain can inhibit VRE growth via the production of a lantibiotic pro- tein (32). We identified a microbiota-intrinsic mechanism that is dependent on lactose uti- lization and favors the"]}
{"query": "You receive the following question:\nQuestion: Does the study detail any statistical methods for determining the sample size used in the experiments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: Which experimental techniques were used in the study to assess Enterococcus levels in patient samples?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: admission to the hospital (range 0\u201324, n = 82). For one patient who underwent liver transplantation, the transplantation date was considered as date of death. Patients were censored at the time point at which they were last seen alive. The baseline characteristics are shown in Supplementary Tables 1, 2. Faecal 16S rRNA sequencing, Enterococcus culture and qPCR were performed. The MELD score, ABIC score and discriminant function were calculated from all alcoholic hepatitis patients from whom\n", "relevant_passages": ["Lactose drives Enterococcus expansion to promote graft-versus-host disease"]}
{"query": "You receive the following question:\nQuestion: Does the text specify any mechanisms or interactions between lactose and bacterial components that could influence graft-versus-host responses?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: What relationship, if any, was observed between cirrhosis and the presence of cytolysin or the levels of faecal E. faecalis in patients with alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Fig. 1g), the proportion of cytolysin-positive patients, total amount of faecal E. faecalis, faecal E. faecalis positivity (Extended Data Fig. 1h\u2013j), treatment and clinical outcomes (30-day and 90-day mortality) did not differ significantly among the regions or centres (Supplemen- tary Table 7). In addition, cirrhosis was not associated with cytolysin positivity, the total amount of faecal E. faecalis or faecal E. faecalis positivity in patients with alcoholic hepatitis (Extended Data Fig. 1k\u2013m,\n", "relevant_passages": ["Phage-based therapies have predominantly been studied in patients with bacterial infections in the gastrointestinal tract21\u201323, urinary tract24,25 and other organ systems26\u201328. The results of these studies\u2014 although mixed in terms of efficacy\u2014strongly suggest that phage treat- ment offers a safe alternative to antibiotics26,27. However, safety studies are required for complex populations (such as patients with alcoholic hepatitis), because phages can induce a strong immune reaction29. Further"]}
{"query": "You receive the following question:\nQuestion: How does the bacteriophage intervention impact the progression of liver disease according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: What role does the bacteriophage play in modulating gut bacterial populations in the context of liver pathology?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: How are faecal Enterococcus amounts affected by the phage intervention in Atp4aSl/Sl mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of\n", "relevant_passages": ["Sample size No power analyses or other calculations were used to predetermine sample sizes. Sample sizes were chosen based on prior literature using similar experimental paradigms (Nat Commun. 2017;8:2137; Gut. 2019;68:1504-1515) Data exclusions No data were excluded Replication In vivo experiments: more than two technical replicates (from different cohorts, on different dates), as well as biological replicates were performed to ensure data reproducibility; In vitro experiments: three"]}
{"query": "You receive the following question:\nQuestion: What difference in faecal E. faecalis counts is observed in patients with alcoholic hepatitis compared to non\u2010alcoholic individuals?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of\n", "relevant_passages": ["with faecal samples that were positive for both cylLL and cylLS DNA sequences (cytolysin-positive), in controls (n = 25), patients with alcohol-use disorder (n = 38) or alcoholic hepatitis (n = 82), assessed by qPCR. Statistically significant differences were detected between controls and patients with alcoholic hepatitis (P < 0.01), and between patients with alcohol- use disorder and patients with alcoholic hepatitis (P < 0.001). c, Kaplan\u2013Meier curve of survival of patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: How does the composition of faecal microbiota in patients with alcoholic hepatitis differ from that in control subjects?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with an altered composition of the faecal microbiota. Differences in faecal microbiota composition were noted in patients with alcohol-use disorder and alcoholic hepatitis, compared to subjects without alcohol- use disorder (controls) (Fig. 1a, Extended Data Fig. 1a, b, Supplementary Tables 1, 2). One substantial difference that we observed was an increase in the proportion of Enterococcus spp. in patients with alcoholic hepa- titis: in these patients, 5.59% of faecal bacteria were Enterococcus\n", "relevant_passages": ["90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: What effect do faecal cytolysin\u2010encoding genes have on patient mortality according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic\n", "relevant_passages": ["Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of"]}
{"query": "You receive the following question:\nQuestion: How does the administration of cytolytic E. faecalis influence the composition of the intestinal microbiota in mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Administration of cytolytic or non-cytolytic E. faecalis to mice did not significantly change the composition of the intestinal microbiota, as shown by 16S rRNA gene sequencing (Extended Data Fig. 2l). Cytolytic E. faecalis did not affect intestinal absorption or hepatic metabolism\n", "relevant_passages": ["DNA from human stool samples, mouse liver sections or bacterial cul- ture was extracted as previously described11, and DNA from mouse faeces was extracted using QIAamp Fast DNA Stool kit (Qiagen). 16S rRNA PCR was completed using Illumina adaptor and barcode-ligated 16S primers targeting the V4 region of the 16S rRNA gene47,48. Amplicons were purified using the Qiaquick PCR purification kit (Qiagen) using manufacturer\u2019s specifications. Purified amplicons were then quantified via TECAN assay"]}
{"query": "You receive the following question:\nQuestion: Which bacterial species is implicated in the secretion of a toxin that contributes to hepatic cell death?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Chronic liver disease due to alcohol-use disorder contributes markedly to the global burden of disease and mortality1\u20133. Alcoholic hepatitis is a severe and life-threatening form of alcohol-associated liver disease. The gut microbiota promotes ethanol- induced liver disease in mice4, but little is known about the microbial factors that are responsible for this process. Here we identify cytolysin\u2014a two-subunit exotoxin that is secreted by Enterococcus faecalis5,6\u2014as a cause of hepatocyte death\n", "relevant_passages": ["spp. compared with almost none in controls (0.023%; for comparison, 0.004% of all reads were Enterococcus spp. in the Human Microbiome Project) or patients with alcohol-use disorder (0.024%). Faecal sam- ples from patients with alcoholic hepatitis had about 2,700-fold more E. faecalis than samples from controls, as measured by quantitative PCR (qPCR) (Extended Data Fig. 1c), which is consistent with the 16S rRNA sequencing results. About 80% of patients with alcoholic hepatitis are positive for"]}
{"query": "You receive the following question:\nQuestion: What methodology was employed to evaluate the impact of cytolysin peptides on liver cells in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine the mechanism by which cytolysin increases liver dis- ease, we isolated hepatocytes from mice fed ethanol or control diets, and stimulated them with pure bioactive cytolysin peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032)6. Incubation of the primary mouse hepatocytes with the two cytolysin subunits caused a dose-dependent increase in cell death compared to hepatocytes that were incubated with vehicle or with one subunit only (Fig. 2h). When we isolated hepatocytes from ethanol-fed mice and then\n", "relevant_passages": ["from GenBank (denoted by black letters) and 19 were from this study (4 phages against cytolysin-positive E. faecalis isolated from mice (shown in blue letters); 7 phages against cytolysin-positive E. faecalis isolated from patients with alcoholic hepatitis (shown in pink letters); and 8 phages against cytolysin- negative E. faecalis isolated from patients with alcoholic hepatitis (shown in green letters)) with Mash43 using a sketch size of s = 5000 and a k-mer size of k = 12 and GGRaSP59"]}
{"query": "You receive the following question:\nQuestion: What information does the study provide about the blinding process during allocation and outcome assessment?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: What significant statistical differences were reported between the patient groups in terms of cyto-lysin positivity?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with faecal samples that were positive for both cylLL and cylLS DNA sequences (cytolysin-positive), in controls (n = 25), patients with alcohol-use disorder (n = 38) or alcoholic hepatitis (n = 82), assessed by qPCR. Statistically significant differences were detected between controls and patients with alcoholic hepatitis (P < 0.01), and between patients with alcohol- use disorder and patients with alcoholic hepatitis (P < 0.001). c, Kaplan\u2013Meier curve of survival of patients with alcoholic\n", "relevant_passages": ["chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT."]}
{"query": "You receive the following question:\nQuestion: What potential immunological concern is associated with phage therapy, especially in complex patient populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Phage-based therapies have predominantly been studied in patients with bacterial infections in the gastrointestinal tract21\u201323, urinary tract24,25 and other organ systems26\u201328. The results of these studies\u2014 although mixed in terms of efficacy\u2014strongly suggest that phage treat- ment offers a safe alternative to antibiotics26,27. However, safety studies are required for complex populations (such as patients with alcoholic hepatitis), because phages can induce a strong immune reaction29. Further\n", "relevant_passages": ["bloodstream infection in allo-HCT patients (5, 8). Patients with severe graft-versus-host disease (GVHD) after allo-HCT have poor outcomes with only ~30% long-term survival (9). Gut microbiota perturbations caused by broad-spectrum antibiotics and a reduction in microbial diversity are associated with in- creased transplant-related mortality and lethal GVHD in humans and mice (10\u201313). Besides causing infections, experimental studies in gno- tobiotic mice have revealed that enterococci play an"]}
{"query": "You receive the following question:\nQuestion: How does the design of the experiment using faeces from cytolysin\u2010negative patients aid in understanding the mechanism of phage treatment in this context?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: What specific phage treatments were administered in the chronic\u2013binge feeding model to target key bacterial populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT.\n", "relevant_passages": ["Hepatocytes were isolated from C57BL/6 female mice fed the chronic\u2013 binge ethanol diet (NIAAA model)15. Livers were perfused in situ with 0.5 mM EGTA containing calcium-free salt solution and then perfused with a solution containing 0.02% (w/v) collagenase D (Roche Applied Science). Livers were then carefully minced and filtered using a 70-\u03bcm nylon cell strainer. Hepatocytes were centrifuged at 50g for 1 min after 3 washes. Hepatocyte viability was assessed by Trypan Blue (Thermo Fisher"]}
{"query": "You receive the following question:\nQuestion: Which hepatic mRNAs are used as indicators of ethanol metabolism in the liver according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice.\n", "relevant_passages": ["Formalin-fixed tissue samples were embedded in paraffin and stained with H & E. To determine lipid accumulation, liver sections were embed- ded in OCT compound. Eight-micrometre frozen sections were then cut and stained with Oil Red O (Sigma-Aldrich). Representative images from each group of mice are shown in each figure. The terminal deoxynucleo- tide transferase-mediated dUTP nick-end labelling (TUNEL) assay was performed using an in situ cell death detection kit (Sigma-Aldrich). We randomly"]}
{"query": "You receive the following question:\nQuestion: What observation has been made in Atp4aSl/Sl mice regarding bacterial overgrowth?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: we investigated the effects of treatment with bacteriophages (here- after, phages). Phages are ubiquitous in bacteria-rich environments, including the gut16. E. faecalis phages that are highly strain-specific can be isolated17, which potentially makes the direct editing of gut microbiota feasible. It has previously been shown that Atp4aSl/Sl mice, which lack gastric acid, have overgrowth of intestinal enterococci, which is associated with increased susceptibility to alcohol-induced\n", "relevant_passages": ["testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable. For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated"]}
{"query": "You receive the following question:\nQuestion: Which genetic components were highlighted in the study in relation to Enterococcus faecalis\u2019s pathogenic potential?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: pathogenicity islands and plasmids14. Detection of any other antimicrobial resistance genes or virulence genes in E. faecalis isolates did not correlate with disease severity or mortality in patients with alcoholic hepatitis (Supplementary Table 4).\n", "relevant_passages": ["To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of"]}
{"query": "You receive the following question:\nQuestion: Is there any evidence in the provided text linking lactose to bacterial expansion or alteration in the gastrointestinal tract?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: failure, such as gastrointestinal bleeding) (Supplementary Table 2). Infection was not associated with 30-day, 90-day or 180-day mortality (P = 0.403, 0.234 or 0.098) in patients with alcoholic hepatitis.\n", "relevant_passages": ["we investigated the effects of treatment with bacteriophages (here- after, phages). Phages are ubiquitous in bacteria-rich environments, including the gut16. E. faecalis phages that are highly strain-specific can be isolated17, which potentially makes the direct editing of gut microbiota feasible. It has previously been shown that Atp4aSl/Sl mice, which lack gastric acid, have overgrowth of intestinal enterococci, which is associated with increased susceptibility to alcohol-induced"]}
{"query": "You receive the following question:\nQuestion: How does an ethanol diet influence the gut barrier and the movement of E. faecalis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: non-cytolytic E. faecalis and fed an ethanol diet, but not when mice were fed an isocaloric (control) diet (Extended Data Fig. 2i); this indicates that ethanol-induced changes in the gut barrier are necessary for the translocation of cytolytic E. faecalis from the intestine to the liver. The livers of ethanol-fed mice that were given cytolytic or non-cytolytic E. faecalis had positive E. faecalis cultures (Extended Data Fig. 2j). We observed an increased intestinal permeability in ethanol-fed\n", "relevant_passages": ["this study plus 54 Enterococcus phage genomes obtained from Gen- Bank, with 5,000 12-mers generated per genome (mash sketch -k 12 -s 5000). The sketch file was then compared to all the initial phage genome sequences to generate the ANI matrix using the mash distance command using default settings. The GGRaSP R package was used to calculate the UPMGA phylogeny from the ANI distance matrix, after redundant phage genomes (genomes ANI >99.985) were removed using the GGRaSP R package with a user"]}
{"query": "You receive the following question:\nQuestion: Which test was applied specifically for survival analysis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: SNP site. P values are determined by permutational multivariate analysis of variance (PERMANOVA) followed by false discovery rate (FDR) procedures (a), two-sided Fisher\u2019s exact test followed by FDR procedures (b) or two-sided log- rank (Mantel\u2013Cox) test (c). The exact group size (n) and P values for each comparison are listed in Supplementary Table 10.\n", "relevant_passages": ["To extend our findings to humans, we colonized germ-free mice with faeces from cytolysin-positive and cytolysin-negative patients with alcoholic hepatitis (Supplementary Table 8). Consistent with our findings from mice colonized with cytolytic E. faecalis, gnotobi- otic C57BL/6 mice colonized with faeces from two cytolysin-positive patients developed more severe ethanol-induced liver injury, steatosis, inflammation and fibrosis than mice given faeces from two cytolysin- negative patients (Fig."]}
{"query": "You receive the following question:\nQuestion: How was the in vivo model used to study the microbiota composition related to patients with alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: What is the proposed therapeutic strategy for treating alcoholic hepatitis mentioned in the text?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: work is required to determine whether phages that target cyto- lytic E. faecalis might be used to treat patients with alcoholic hepatitis, a life-threatening disease that at present has no effective treatment. Eradication of this specific bacterial strain might produce better out- comes than current treatments, and environmental sources can be used to easily isolate phages that target cytolysin-positive E. faecalis. Here we provide an example of the efficacy of approaches based on phages in mice\n", "relevant_passages": ["important role in colitis (14) by stimulat- ing antigen-presenting cells and CD4+RORg+ T cell infiltration, causing intestinal inflam- mation (15). In this study, we investigated the role of enterococci in the development of acute GVHD, both in allo-HCT patients and preclinical allo-HCT mouse models."]}
{"query": "You receive the following question:\nQuestion: How effective is corticosteroid therapy for patients with severe alcoholic hepatitis as described in the content?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The most severe form of alcohol-related liver disease is alcoholic hepa- titis; mortality ranges from 20% to 40% at 1\u20136 months, and as many as 75% of patients die within 90 days of a diagnosis of severe alcoholic hepatitis7\u20139. Therapy with corticosteroids is only marginally effective9. Early liver transplantation is the only curative therapy, but is offered only at select centres and to a limited group of patients10.\n", "relevant_passages": ["The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive"]}
{"query": "You receive the following question:\nQuestion: What aspects of the disease are being investigated with respect to microbial influence?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: What unique characteristic does the E. faecalis strain isolated from the Atp4aSl/Sl mice possess?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: steatohepatitis11. The gavaging of wild-type mice with an E. faecalis strain isolated from Atp4aSl/Sl mice led to increased ethanol-induced steatohepatitis11. We found that this same E. faecalis strain expressed cytolysin. We then isolated four distinct phages from sewage water. These phages lyse the cytolytic E. faecalis strain isolated from Atp4aSl/Sl mice. All four phages were podophages of the virulent Picovirinae group (Extended Data Fig. 4). Atp4aSl/Sl mice and their wild-type littermates\n", "relevant_passages": ["Bacteriophage sequencing and phage tree: Albacore v2.3.4 (ONT), Porechop v0.2.3, Unicycler v0.4.7 pipeline, Pilon v1.22, CLC Genomics Workbench 4.9, NCBI Prokaryotic Genome Annotation Pipeline, in-house PERL script using Xfig, Phage_Finder, MASH program, GGRaSP and APE R-package, iTOL tree viewer 16S sequencing: MOTHUR-based 16S rDNA analysis workflow E. faecalis genome sequencing and tree: abricate v0.8.10 , Prokka, Roary, RAXML, iTOL Statistical analyses: R"]}
{"query": "You receive the following question:\nQuestion: How does gavaging with cytolytic E. faecalis affect liver inflammation and cytokine expression compared to the PBS control?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: How does the colonization of mice with E. faecalis affect the liver according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive\n", "relevant_passages": ["cytolytic E. faecalis to the liver after ethanol administration (Fig. 2g). The overall composition of the intestinal microbiota was not differ- ent between mice fed the control diet and colonized with faeces from cytolysin-positive or cytolysin-negative donors with alcoholic hepatitis, as shown by 16S rRNA gene sequencing. Mice transplanted with faeces from one of the cytolysin-positive patients with alcoholic hepatitis (patient no. 2) showed a microbiota that was significantly different from"]}
{"query": "You receive the following question:\nQuestion: How does gastric acid suppression affect the intestinal microbiota according to Llorente et al.?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 11. Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat. Commun. 8, 837 (2017).\n", "relevant_passages": ["and Parabacteroides diastonis; see materials and methods) (10, 18, 19) 21 days prior to allo-HCT (LP/J\u2192gnotobiotic C57BL/6). One group of mice was cocolonized on day \u221221 with E. faecalis OG1RF, which remained detectable in mouse feces on days 0 and +7 (Fig. 2D, right panel, and fig. S4E). GVHD was exacerbated in E. faecalis\u2013harboring mice"]}
{"query": "You receive the following question:\nQuestion: What specific components were used in the incubation experiments to assess hepatocyte survival?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: groups, right), and incubated with vehicle, CylLS\u2032\u2032, CylLL\u2032\u2032 or both of the cytolysin subunits at the indicated concentrations without (\u2013) or with (+) ethanol (25 mM) for 3 h. The survival of hepatocytes was determined in three independent experiments. Scale bar, 100 \u03bcm. Results are expressed as mean \u00b1 s.e.m. (a, b, d\u2013f, h). P values are determined by one-way analysis of variance (ANOVA) with Tukey\u2019s post hoc test (a, b, d\u2013f), two-sided Fisher\u2019s exact test followed by FDR procedures (g) or\n", "relevant_passages": ["Plus fragment library kit and sequenced using a 316 Chip on an Ion Torrent Personal Genome Machine (Life Technologies). Reads were trimmed according to modified Phred scores of 0.5 using CLC Genomics Workbench 4.9 (Cambridge), and the remaining reads were assembled using CLC Genomics Workbench 4.9 based on 98% identity with a minimum of 50% read overlap39. Reads were assembled into a single contig of 18,186 bp (20,118 \u00d7 coverage)."]}
{"query": "You receive the following question:\nQuestion: What information does the construction of a core genome SNP tree provide regarding the method of evaluating E. faecalis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis whose faecal samples were cytolysin-positive (n = 25) or cytolysin-negative (n = 54) (P < 0.0001). d, Core genome single-nucleotide polymorphism (SNP) tree of E. faecalis strains isolated from patients with alcoholic hepatitis (n = 93 strains, from 24 patients), showing phylogenetic diversity of cytolysin-positive (red) E. faecalis. Genomically identical isolates from the same patient were combined, and are shown as a single dot. Scale bar represents the nucleotide substitutions per\n", "relevant_passages": ["of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice."]}
{"query": "You receive the following question:\nQuestion: What specific characteristic of E. faecalis determines the severity of alcoholic hepatitis according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Supplementary Tables 4\u20136). These results confirm our findings that the presence of cytolysin-producing E. faecalis rather than the total amount or presence of E. faecalis per se determines the severity of alcoholic hepatitis and mortality.\n", "relevant_passages": ["work is required to determine whether phages that target cyto- lytic E. faecalis might be used to treat patients with alcoholic hepatitis, a life-threatening disease that at present has no effective treatment. Eradication of this specific bacterial strain might produce better out- comes than current treatments, and environmental sources can be used to easily isolate phages that target cytolysin-positive E. faecalis. Here we provide an example of the efficacy of approaches based on phages in mice"]}
{"query": "You receive the following question:\nQuestion: What evidence supports the occurrence of bacterial translocation from the gut to the liver in ethanol-fed mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: non-cytolytic E. faecalis and fed an ethanol diet, but not when mice were fed an isocaloric (control) diet (Extended Data Fig. 2i); this indicates that ethanol-induced changes in the gut barrier are necessary for the translocation of cytolytic E. faecalis from the intestine to the liver. The livers of ethanol-fed mice that were given cytolytic or non-cytolytic E. faecalis had positive E. faecalis cultures (Extended Data Fig. 2j). We observed an increased intestinal permeability in ethanol-fed\n", "relevant_passages": ["this study plus 54 Enterococcus phage genomes obtained from Gen- Bank, with 5,000 12-mers generated per genome (mash sketch -k 12 -s 5000). The sketch file was then compared to all the initial phage genome sequences to generate the ANI matrix using the mash distance command using default settings. The GGRaSP R package was used to calculate the UPMGA phylogeny from the ANI distance matrix, after redundant phage genomes (genomes ANI >99.985) were removed using the GGRaSP R package with a user"]}
{"query": "You receive the following question:\nQuestion: What differences in liver pathology were observed when mice gavaged with non-cytolytic E. faecalis were fed ethanol?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: In comparison to widely-used models like MELD and ABIC, how does the predictive capability of cytolysin stand out for mortality prediction?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis. When we performed receiver-operating-characteristic curve analysis for 90-day mortality, cytolysin had an area under the curve of 0.81, which was superior to other widely used predictors for mortality in clinical practice (Extended Data Fig. 1e). On the basis of our findings, we propose that the detection of cytolysin may be a prognostic factor for more severe liver- related outcomes and increased risk of death, and a stronger predictor of mortality than MELD, ABIC and the\n", "relevant_passages": ["To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and"]}
{"query": "You receive the following question:\nQuestion: What evidence supports the role of cytolysin in influencing microbial dynamics that could drive disease processes?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes\n", "relevant_passages": ["followed by FDR procedures for multiple group comparisons. Jaccard dissimilarity matrices were used for PCoA, and P values were determined by PERMANOVA followed by FDR procedures to correct for multiple comparisons."]}
{"query": "You receive the following question:\nQuestion: What predictive biomarker has the study data identified for severe alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: for a disease that is not considered a classic infectious disease. Our data also suggest that cytolysin may be used as a predictive biomarker of severe alcoholic hepatitis; an independent, prospective\n", "relevant_passages": ["We used 16S ribosomal RNA (rRNA) gene sequencing to study the fecal microbiota of 1325 adult allo-HCT recipients at four HCT centers: Memorial Sloan Kettering Cancer"]}
{"query": "You receive the following question:\nQuestion: What effect does cytolytic E. faecalis have on intestinal absorption in mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Administration of cytolytic or non-cytolytic E. faecalis to mice did not significantly change the composition of the intestinal microbiota, as shown by 16S rRNA gene sequencing (Extended Data Fig. 2l). Cytolytic E. faecalis did not affect intestinal absorption or hepatic metabolism\n", "relevant_passages": ["DNA from human stool samples, mouse liver sections or bacterial cul- ture was extracted as previously described11, and DNA from mouse faeces was extracted using QIAamp Fast DNA Stool kit (Qiagen). 16S rRNA PCR was completed using Illumina adaptor and barcode-ligated 16S primers targeting the V4 region of the 16S rRNA gene47,48. Amplicons were purified using the Qiaquick PCR purification kit (Qiagen) using manufacturer\u2019s specifications. Purified amplicons were then quantified via TECAN assay"]}
{"query": "You receive the following question:\nQuestion: What details about patient sample collection and clinical data are described in the text, and do they include any insights into microbiological components like lactose?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were recruited from an alcohol withdrawal unit in San Diego and Brussels, where they followed a detoxification and rehabilitation programme. At admission to the hospital, a complete medication and medical history was taken, and a complete physical examination was performed, including collection of bio-specimens, basic demographic data (such as age, gender, weight and height) and self-reported daily alcohol consumption. Patients were actively drink- ing until the day of admission. Controls or\n", "relevant_passages": ["expansion of enterococci. This process may be triggered through a loss of lactase produced by enterocytes damaged by conditioning or allo-reactive T cells. We validated this concept experimentally, by showing that depletion of lactose in vitro and in vivo inhibited enterococcal expan- sion and mitigated GVHD, and clinically, by showing that patients harboring a lactose- malabsorption allele experienced prolonged Enterococcus domination after antibiotic ex- posure. These observations in mice and"]}
{"query": "You receive the following question:\nQuestion: How does cytolysin positivity correlate with mortality outcomes in alcoholic hepatitis patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)\n", "relevant_passages": ["that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes"]}
{"query": "You receive the following question:\nQuestion: Which treatment is identified as the only curative option for severe alcoholic hepatitis, and what limitations does it have?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The most severe form of alcohol-related liver disease is alcoholic hepa- titis; mortality ranges from 20% to 40% at 1\u20136 months, and as many as 75% of patients die within 90 days of a diagnosis of severe alcoholic hepatitis7\u20139. Therapy with corticosteroids is only marginally effective9. Early liver transplantation is the only curative therapy, but is offered only at select centres and to a limited group of patients10.\n", "relevant_passages": ["The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive"]}
{"query": "You receive the following question:\nQuestion: Which disease is identified in the study as being transmissible through the faecal microbiota?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: Which diagnostic procedure was utilized to confirm the presence of alcoholic hepatitis when it was clinically indicated?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: lack of signed informed consent. In all patients, the clinical picture was consistent with alcoholic hepatitis and in patients who underwent liver biopsy, the histology was consistent with the diagnosis of alco- holic hepatitis. Liver biopsies were only done if clinically indicated as part of routine clinical care for diagnostic purposes of alcoholic hepatitis. Bio-specimens were collected during their admission to the hospital. The median time of specimen collection was 4 days fol- lowing\n", "relevant_passages": ["Ferring Pharmaceuticals; is an inventor on patent application number WPO2015179437A1, entitled \u201cMethods and compositions for reducing Clostridium difficile infection,\u201d and patent number WPO2017091753A1, entitled \u201cMethods and compositions for reducing vancomycin-resistant Enterococci infection or colonization\u201d; and holds patents that receive royalties from Seres Therapeutics Inc. Other authors have no competing interests. Data and materials availability: All data are available in the manuscript"]}
{"query": "You receive the following question:\nQuestion: How does the analysis confirm that the effect of cytolysin is independent of other clinical factors?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic\n", "relevant_passages": ["Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of"]}
{"query": "You receive the following question:\nQuestion: What are the characteristics of the phage-based therapeutic agents described in the study, and how are they customized for individual patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: What distinct morphological characteristics were noted for the phages isolated against the cytolytic E. faecalis strains?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: Is there any discussion in the content regarding mechanisms that could be linked to graft\u2010versus\u2010host disease or the influence of specific nutrients like lactose on microbial populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were recruited from an alcohol withdrawal unit in San Diego and Brussels, where they followed a detoxification and rehabilitation programme. At admission to the hospital, a complete medication and medical history was taken, and a complete physical examination was performed, including collection of bio-specimens, basic demographic data (such as age, gender, weight and height) and self-reported daily alcohol consumption. Patients were actively drink- ing until the day of admission. Controls or\n", "relevant_passages": ["expansion of enterococci. This process may be triggered through a loss of lactase produced by enterocytes damaged by conditioning or allo-reactive T cells. We validated this concept experimentally, by showing that depletion of lactose in vitro and in vivo inhibited enterococcal expan- sion and mitigated GVHD, and clinically, by showing that patients harboring a lactose- malabsorption allele experienced prolonged Enterococcus domination after antibiotic ex- posure. These observations in mice and"]}
{"query": "You receive the following question:\nQuestion: Which pro-inflammatory mediator is reduced following the lytic phage treatment targeting cytolytic E. faecalis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: How does the application of these lytic phages influence ethanol-induced liver injury and associated pathological markers?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: How do the findings exclude ethanol metabolism differences as a factor in the observed microbial effects?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes\n", "relevant_passages": ["followed by FDR procedures for multiple group comparisons. Jaccard dissimilarity matrices were used for PCoA, and P values were determined by PERMANOVA followed by FDR procedures to correct for multiple comparisons."]}
{"query": "You receive the following question:\nQuestion: How does the experimental design differentiate between the control and targeted phage treatments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT.\n", "relevant_passages": ["Hepatocytes were isolated from C57BL/6 female mice fed the chronic\u2013 binge ethanol diet (NIAAA model)15. Livers were perfused in situ with 0.5 mM EGTA containing calcium-free salt solution and then perfused with a solution containing 0.02% (w/v) collagenase D (Roche Applied Science). Livers were then carefully minced and filtered using a 70-\u03bcm nylon cell strainer. Hepatocytes were centrifuged at 50g for 1 min after 3 washes. Hepatocyte viability was assessed by Trypan Blue (Thermo Fisher"]}
{"query": "You receive the following question:\nQuestion: Based on the provided content, what details are available regarding lactose's biochemical role in expanding Enterococcus populations in graft-versus-host disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: How did the treatment with lytic phages influence ethanol-induced liver disease in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: ethanol-induced liver disease compared with control phages (Fig. 4b\u2013g, Extended Data Fig. 9a\u2013h), despite the reduc- tion of faecal Enterococcus (Fig. 4h). Our findings indicate that treat- ment with lytic phages can selectively attenuate the ethanol-induced liver disease caused by cytolysin-positive E. faecalis in humanized mice.\n", "relevant_passages": ["exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease."]}
{"query": "You receive the following question:\nQuestion: Based on the paper, what is the mechanism by which bacteriophage application influences disease outcomes?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: At what point during the hospital admission were bio-specimens collected from the patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: lack of signed informed consent. In all patients, the clinical picture was consistent with alcoholic hepatitis and in patients who underwent liver biopsy, the histology was consistent with the diagnosis of alco- holic hepatitis. Liver biopsies were only done if clinically indicated as part of routine clinical care for diagnostic purposes of alcoholic hepatitis. Bio-specimens were collected during their admission to the hospital. The median time of specimen collection was 4 days fol- lowing\n", "relevant_passages": ["Ferring Pharmaceuticals; is an inventor on patent application number WPO2015179437A1, entitled \u201cMethods and compositions for reducing Clostridium difficile infection,\u201d and patent number WPO2017091753A1, entitled \u201cMethods and compositions for reducing vancomycin-resistant Enterococci infection or colonization\u201d; and holds patents that receive royalties from Seres Therapeutics Inc. Other authors have no competing interests. Data and materials availability: All data are available in the manuscript"]}
{"query": "You receive the following question:\nQuestion: Which molecular markers were upregulated in mice showing heightened liver inflammation due to cytolytic E. faecalis exposure?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: What biochemical evidence supports the involvement of ethanol in liver pathology as described in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice.\n", "relevant_passages": ["Formalin-fixed tissue samples were embedded in paraffin and stained with H & E. To determine lipid accumulation, liver sections were embed- ded in OCT compound. Eight-micrometre frozen sections were then cut and stained with Oil Red O (Sigma-Aldrich). Representative images from each group of mice are shown in each figure. The terminal deoxynucleo- tide transferase-mediated dUTP nick-end labelling (TUNEL) assay was performed using an in situ cell death detection kit (Sigma-Aldrich). We randomly"]}
{"query": "You receive the following question:\nQuestion: What role did the ethanol-fed mouse model play in the experimental design regarding cytolysin\u2019s effect?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine the mechanism by which cytolysin increases liver dis- ease, we isolated hepatocytes from mice fed ethanol or control diets, and stimulated them with pure bioactive cytolysin peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032)6. Incubation of the primary mouse hepatocytes with the two cytolysin subunits caused a dose-dependent increase in cell death compared to hepatocytes that were incubated with vehicle or with one subunit only (Fig. 2h). When we isolated hepatocytes from ethanol-fed mice and then\n", "relevant_passages": ["from GenBank (denoted by black letters) and 19 were from this study (4 phages against cytolysin-positive E. faecalis isolated from mice (shown in blue letters); 7 phages against cytolysin-positive E. faecalis isolated from patients with alcoholic hepatitis (shown in pink letters); and 8 phages against cytolysin- negative E. faecalis isolated from patients with alcoholic hepatitis (shown in green letters)) with Mash43 using a sketch size of s = 5000 and a k-mer size of k = 12 and GGRaSP59"]}
{"query": "You receive the following question:\nQuestion: Where can detailed information on group sizes and P values be found as mentioned in the text regarding the study's comparisons?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: two-way ANOVA with Tukey\u2019s post hoc test (h). All results were generated from at least three independent replicates. The exact group size (n) and P values for each comparison are listed in Supplementary Table 10. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\n", "relevant_passages": ["Mapping of ONT reads to the hybrid assemblies was used to deter- mine the orientation and terminal ends of linear phage genomes, and reference genomes served as guides to orient circular phage genomes. Phage genome assemblies were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP)40,41."]}
{"query": "You receive the following question:\nQuestion: What microbial alteration is associated with alcoholic hepatitis as noted in the research data?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with an altered composition of the faecal microbiota. Differences in faecal microbiota composition were noted in patients with alcohol-use disorder and alcoholic hepatitis, compared to subjects without alcohol- use disorder (controls) (Fig. 1a, Extended Data Fig. 1a, b, Supplementary Tables 1, 2). One substantial difference that we observed was an increase in the proportion of Enterococcus spp. in patients with alcoholic hepa- titis: in these patients, 5.59% of faecal bacteria were Enterococcus\n", "relevant_passages": ["90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: Which subset of E. faecalis is specifically targeted by the phage treatment described in the study, and how was this selectivity demonstrated?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: What genetic elements were targeted to identify cytolysin-positive samples in the study, and how were they detected?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)\n", "relevant_passages": ["that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes"]}
{"query": "You receive the following question:\nQuestion: What genetic element is implicated in mediating the variability of cytolysin production in E. faecalis, as per the research?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine phylogeny of E. faecalis in patients with alcoholic hepatitis, we performed targeted culturing from stool samples. Whole- genome sequencing of 93 E. faecalis isolates revealed a broad phylo- genetic diversity of cytolysin-positive E. faecalis from patients with alcoholic hepatitis (Fig. 1d), which indicates that cytolysin production is a variable trait among E. faecalis isolates and that cytolysin is car- ried in mobile genetic elements, which include both chromosomally encoded\n", "relevant_passages": ["Cxcl1, Cxcl2, Col1a1 and Acta2 mRNAs, and reduced hepatic levels of cylLS, as compared with mice given control phages (against C. crescentus) (Fig. 3e\u2013h, Extended Data Fig. 7c, d). Treatment with phages against cytolytic E. faecalis also reduced faecal amounts of Enterococcus (Extended Data Fig. 7e) without affecting the overall composition of the gut microbiota (Extended Data Fig. 7f). Intestinal absorption of ethanol and hepatic metabolism were similar in all groups (Extended Data Fig. 7g, h)."]}
{"query": "You receive the following question:\nQuestion: Which specific strain of Enterococcus is implicated in the observed liver disease, and how was it characterized?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: ethanol-induced liver disease compared with control phages (Fig. 4b\u2013g, Extended Data Fig. 9a\u2013h), despite the reduc- tion of faecal Enterococcus (Fig. 4h). Our findings indicate that treat- ment with lytic phages can selectively attenuate the ethanol-induced liver disease caused by cytolysin-positive E. faecalis in humanized mice.\n", "relevant_passages": ["exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease."]}
{"query": "You receive the following question:\nQuestion: What experimental model was used to extend the microbiological findings to human-derived samples?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To extend our findings to humans, we colonized germ-free mice with faeces from cytolysin-positive and cytolysin-negative patients with alcoholic hepatitis (Supplementary Table 8). Consistent with our findings from mice colonized with cytolytic E. faecalis, gnotobi- otic C57BL/6 mice colonized with faeces from two cytolysin-positive patients developed more severe ethanol-induced liver injury, steatosis, inflammation and fibrosis than mice given faeces from two cytolysin- negative patients (Fig.\n", "relevant_passages": ["Results are expressed as mean \u00b1 s.e.m. (except when stated otherwise). Univariate and multivariate Cox regression analysis was used to detect associations of cytolysin with overall mortality. The multivariate model was adjusted for geographical origin of the patients, antibiotic treat- ment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. Univariate logistic regression analysis of laboratory and clinical parameters associated with the detection of cytolysin and"]}
{"query": "You receive the following question:\nQuestion: Which intervention discussed in the study triggers a shift in microbial composition that contributes to liver pathology?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 11. Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat. Commun. 8, 837 (2017).\n", "relevant_passages": ["and Parabacteroides diastonis; see materials and methods) (10, 18, 19) 21 days prior to allo-HCT (LP/J\u2192gnotobiotic C57BL/6). One group of mice was cocolonized on day \u221221 with E. faecalis OG1RF, which remained detectable in mouse feces on days 0 and +7 (Fig. 2D, right panel, and fig. S4E). GVHD was exacerbated in E. faecalis\u2013harboring mice"]}
{"query": "You receive the following question:\nQuestion: From what source were the phages against non-cytolytic E. faecalis isolated, and what morphological characteristics did they exhibit?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: Which microbial elements are proposed as contributing to the progression of the disease according to the text?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: What type of E. faecalis strains were cultured in this study and what was their clinical source?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: How were experiments conducted with respect to randomization procedures?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: Are there any studies or findings in the excerpt that address the role of bacterial metabolism, such as Enterococcus expansion, in mediating immune responses in disease settings like graft-versus-host disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: What experimental approach was used to determine the phylogeny of E. faecalis in patients with alcoholic hepatitis, and what did it reveal about cytolysin production?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine phylogeny of E. faecalis in patients with alcoholic hepatitis, we performed targeted culturing from stool samples. Whole- genome sequencing of 93 E. faecalis isolates revealed a broad phylo- genetic diversity of cytolysin-positive E. faecalis from patients with alcoholic hepatitis (Fig. 1d), which indicates that cytolysin production is a variable trait among E. faecalis isolates and that cytolysin is car- ried in mobile genetic elements, which include both chromosomally encoded\n", "relevant_passages": ["Cxcl1, Cxcl2, Col1a1 and Acta2 mRNAs, and reduced hepatic levels of cylLS, as compared with mice given control phages (against C. crescentus) (Fig. 3e\u2013h, Extended Data Fig. 7c, d). Treatment with phages against cytolytic E. faecalis also reduced faecal amounts of Enterococcus (Extended Data Fig. 7e) without affecting the overall composition of the gut microbiota (Extended Data Fig. 7f). Intestinal absorption of ethanol and hepatic metabolism were similar in all groups (Extended Data Fig. 7g, h)."]}
{"query": "You receive the following question:\nQuestion: How is cytolysin proposed to influence liver-related outcomes and the risk of death according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis. When we performed receiver-operating-characteristic curve analysis for 90-day mortality, cytolysin had an area under the curve of 0.81, which was superior to other widely used predictors for mortality in clinical practice (Extended Data Fig. 1e). On the basis of our findings, we propose that the detection of cytolysin may be a prognostic factor for more severe liver- related outcomes and increased risk of death, and a stronger predictor of mortality than MELD, ABIC and the\n", "relevant_passages": ["To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and"]}
{"query": "You receive the following question:\nQuestion: How do bacteriophages modify the levels of cytolysin in the liver, and what effect does this have in the mouse model?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacteriophages that target cytolytic E. faecalis. We found that these bacteriophages decrease cytolysin in the liver and abolish ethanol-induced liver disease in humanized mice. Our findings link cytolytic E. faecalis with more severe clinical outcomes and increased mortality in patients with alcoholic hepatitis. We show that bacteriophages can specifically target cytolytic E. faecalis, which provides a method for precisely editing the intestinal microbiota. A clinical trial with a larger cohort\n", "relevant_passages": ["hepatitis whose faecal samples were cytolysin-positive (n = 25) or cytolysin-negative (n = 54) (P < 0.0001). d, Core genome single-nucleotide polymorphism (SNP) tree of E. faecalis strains isolated from patients with alcoholic hepatitis (n = 93 strains, from 24 patients), showing phylogenetic diversity of cytolysin-positive (red) E. faecalis. Genomically identical isolates from the same patient were combined, and are shown as a single dot. Scale bar represents the nucleotide substitutions per"]}
{"query": "You receive the following question:\nQuestion: How does the cytolytic E. faecalis strain (FA2-2(pAM714)) influence liver injury in ethanol-fed mice relative to control treatments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine whether cytolysin contributes to liver damage mediated by E. faecalis, we gavaged mice with a cytolytic E. faecalis strain (FA2- 2(pAM714)) or a non-cytolytic E. faecalis strain (FA2-2(pAM771))5; the mice were then placed on a chronic\u2013binge ethanol diet15. Compared to mice gavaged with phosphate-buffered saline (PBS), mice fed with ethanol after they were gavaged with cytolytic E. faecalis developed more severe liver injury as indicated by a higher level of alanine amino-\n", "relevant_passages": ["7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012)."]}
{"query": "You receive the following question:\nQuestion: How is the disease described in terms of its classification as an infectious disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: for a disease that is not considered a classic infectious disease. Our data also suggest that cytolysin may be used as a predictive biomarker of severe alcoholic hepatitis; an independent, prospective\n", "relevant_passages": ["We used 16S ribosomal RNA (rRNA) gene sequencing to study the fecal microbiota of 1325 adult allo-HCT recipients at four HCT centers: Memorial Sloan Kettering Cancer"]}
=======
{"query": "You receive the following question:\nQuestion: What specific criteria were used in the study to define patients with alcohol-use disorder?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 26 subjects without alcohol-use disorder (controls; social drinkers consuming less than 20 g/day), 44 patients with alcohol-use disorder and 88 patients with alcoholic hepatitis. Patients with alcohol-use disorder fulfilling the DSM IV criteria33 of alcohol dependence and with active alcohol consumption (self-reported >60 g/day) presented with various stages of liver disease (21% had advanced F3/4 fibrosis based on fibrosis-4 index) (Supplementary Table 1). Patients with alcohol-use disorder\n", "relevant_passages": ["responses (31). We previously identified Blautia abundance (a genus within class Clostridia) as a predictor of protection from lethal GVHD (12), whereas here we describe Enterococcus domination as a risk factor for GVHD. These two findings are noteworthy in light of our recent observa- tion that a B. producta strain can inhibit VRE growth via the production of a lantibiotic pro- tein (32). We identified a microbiota-intrinsic mechanism that is dependent on lactose uti- lization and favors the"]}
{"query": "You receive the following question:\nQuestion: Does the study detail any statistical methods for determining the sample size used in the experiments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: Which experimental techniques were used in the study to assess Enterococcus levels in patient samples?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: admission to the hospital (range 0\u201324, n = 82). For one patient who underwent liver transplantation, the transplantation date was considered as date of death. Patients were censored at the time point at which they were last seen alive. The baseline characteristics are shown in Supplementary Tables 1, 2. Faecal 16S rRNA sequencing, Enterococcus culture and qPCR were performed. The MELD score, ABIC score and discriminant function were calculated from all alcoholic hepatitis patients from whom\n", "relevant_passages": ["Lactose drives Enterococcus expansion to promote graft-versus-host disease"]}
{"query": "You receive the following question:\nQuestion: Does the text specify any mechanisms or interactions between lactose and bacterial components that could influence graft-versus-host responses?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: What relationship, if any, was observed between cirrhosis and the presence of cytolysin or the levels of faecal E. faecalis in patients with alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Fig. 1g), the proportion of cytolysin-positive patients, total amount of faecal E. faecalis, faecal E. faecalis positivity (Extended Data Fig. 1h\u2013j), treatment and clinical outcomes (30-day and 90-day mortality) did not differ significantly among the regions or centres (Supplemen- tary Table 7). In addition, cirrhosis was not associated with cytolysin positivity, the total amount of faecal E. faecalis or faecal E. faecalis positivity in patients with alcoholic hepatitis (Extended Data Fig. 1k\u2013m,\n", "relevant_passages": ["Phage-based therapies have predominantly been studied in patients with bacterial infections in the gastrointestinal tract21\u201323, urinary tract24,25 and other organ systems26\u201328. The results of these studies\u2014 although mixed in terms of efficacy\u2014strongly suggest that phage treat- ment offers a safe alternative to antibiotics26,27. However, safety studies are required for complex populations (such as patients with alcoholic hepatitis), because phages can induce a strong immune reaction29. Further"]}
{"query": "You receive the following question:\nQuestion: How does the bacteriophage intervention impact the progression of liver disease according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: What role does the bacteriophage play in modulating gut bacterial populations in the context of liver pathology?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: How are faecal Enterococcus amounts affected by the phage intervention in Atp4aSl/Sl mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of\n", "relevant_passages": ["Sample size No power analyses or other calculations were used to predetermine sample sizes. Sample sizes were chosen based on prior literature using similar experimental paradigms (Nat Commun. 2017;8:2137; Gut. 2019;68:1504-1515) Data exclusions No data were excluded Replication In vivo experiments: more than two technical replicates (from different cohorts, on different dates), as well as biological replicates were performed to ensure data reproducibility; In vitro experiments: three"]}
{"query": "You receive the following question:\nQuestion: What difference in faecal E. faecalis counts is observed in patients with alcoholic hepatitis compared to non\u2010alcoholic individuals?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of\n", "relevant_passages": ["with faecal samples that were positive for both cylLL and cylLS DNA sequences (cytolysin-positive), in controls (n = 25), patients with alcohol-use disorder (n = 38) or alcoholic hepatitis (n = 82), assessed by qPCR. Statistically significant differences were detected between controls and patients with alcoholic hepatitis (P < 0.01), and between patients with alcohol- use disorder and patients with alcoholic hepatitis (P < 0.001). c, Kaplan\u2013Meier curve of survival of patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: How does the composition of faecal microbiota in patients with alcoholic hepatitis differ from that in control subjects?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with an altered composition of the faecal microbiota. Differences in faecal microbiota composition were noted in patients with alcohol-use disorder and alcoholic hepatitis, compared to subjects without alcohol- use disorder (controls) (Fig. 1a, Extended Data Fig. 1a, b, Supplementary Tables 1, 2). One substantial difference that we observed was an increase in the proportion of Enterococcus spp. in patients with alcoholic hepa- titis: in these patients, 5.59% of faecal bacteria were Enterococcus\n", "relevant_passages": ["90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: What effect do faecal cytolysin\u2010encoding genes have on patient mortality according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic\n", "relevant_passages": ["Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of"]}
{"query": "You receive the following question:\nQuestion: How does the administration of cytolytic E. faecalis influence the composition of the intestinal microbiota in mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Administration of cytolytic or non-cytolytic E. faecalis to mice did not significantly change the composition of the intestinal microbiota, as shown by 16S rRNA gene sequencing (Extended Data Fig. 2l). Cytolytic E. faecalis did not affect intestinal absorption or hepatic metabolism\n", "relevant_passages": ["DNA from human stool samples, mouse liver sections or bacterial cul- ture was extracted as previously described11, and DNA from mouse faeces was extracted using QIAamp Fast DNA Stool kit (Qiagen). 16S rRNA PCR was completed using Illumina adaptor and barcode-ligated 16S primers targeting the V4 region of the 16S rRNA gene47,48. Amplicons were purified using the Qiaquick PCR purification kit (Qiagen) using manufacturer\u2019s specifications. Purified amplicons were then quantified via TECAN assay"]}
{"query": "You receive the following question:\nQuestion: Which bacterial species is implicated in the secretion of a toxin that contributes to hepatic cell death?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Chronic liver disease due to alcohol-use disorder contributes markedly to the global burden of disease and mortality1\u20133. Alcoholic hepatitis is a severe and life-threatening form of alcohol-associated liver disease. The gut microbiota promotes ethanol- induced liver disease in mice4, but little is known about the microbial factors that are responsible for this process. Here we identify cytolysin\u2014a two-subunit exotoxin that is secreted by Enterococcus faecalis5,6\u2014as a cause of hepatocyte death\n", "relevant_passages": ["spp. compared with almost none in controls (0.023%; for comparison, 0.004% of all reads were Enterococcus spp. in the Human Microbiome Project) or patients with alcohol-use disorder (0.024%). Faecal sam- ples from patients with alcoholic hepatitis had about 2,700-fold more E. faecalis than samples from controls, as measured by quantitative PCR (qPCR) (Extended Data Fig. 1c), which is consistent with the 16S rRNA sequencing results. About 80% of patients with alcoholic hepatitis are positive for"]}
{"query": "You receive the following question:\nQuestion: What methodology was employed to evaluate the impact of cytolysin peptides on liver cells in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine the mechanism by which cytolysin increases liver dis- ease, we isolated hepatocytes from mice fed ethanol or control diets, and stimulated them with pure bioactive cytolysin peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032)6. Incubation of the primary mouse hepatocytes with the two cytolysin subunits caused a dose-dependent increase in cell death compared to hepatocytes that were incubated with vehicle or with one subunit only (Fig. 2h). When we isolated hepatocytes from ethanol-fed mice and then\n", "relevant_passages": ["from GenBank (denoted by black letters) and 19 were from this study (4 phages against cytolysin-positive E. faecalis isolated from mice (shown in blue letters); 7 phages against cytolysin-positive E. faecalis isolated from patients with alcoholic hepatitis (shown in pink letters); and 8 phages against cytolysin- negative E. faecalis isolated from patients with alcoholic hepatitis (shown in green letters)) with Mash43 using a sketch size of s = 5000 and a k-mer size of k = 12 and GGRaSP59"]}
{"query": "You receive the following question:\nQuestion: What information does the study provide about the blinding process during allocation and outcome assessment?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: What significant statistical differences were reported between the patient groups in terms of cyto-lysin positivity?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with faecal samples that were positive for both cylLL and cylLS DNA sequences (cytolysin-positive), in controls (n = 25), patients with alcohol-use disorder (n = 38) or alcoholic hepatitis (n = 82), assessed by qPCR. Statistically significant differences were detected between controls and patients with alcoholic hepatitis (P < 0.01), and between patients with alcohol- use disorder and patients with alcoholic hepatitis (P < 0.001). c, Kaplan\u2013Meier curve of survival of patients with alcoholic\n", "relevant_passages": ["chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT."]}
{"query": "You receive the following question:\nQuestion: What potential immunological concern is associated with phage therapy, especially in complex patient populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Phage-based therapies have predominantly been studied in patients with bacterial infections in the gastrointestinal tract21\u201323, urinary tract24,25 and other organ systems26\u201328. The results of these studies\u2014 although mixed in terms of efficacy\u2014strongly suggest that phage treat- ment offers a safe alternative to antibiotics26,27. However, safety studies are required for complex populations (such as patients with alcoholic hepatitis), because phages can induce a strong immune reaction29. Further\n", "relevant_passages": ["bloodstream infection in allo-HCT patients (5, 8). Patients with severe graft-versus-host disease (GVHD) after allo-HCT have poor outcomes with only ~30% long-term survival (9). Gut microbiota perturbations caused by broad-spectrum antibiotics and a reduction in microbial diversity are associated with in- creased transplant-related mortality and lethal GVHD in humans and mice (10\u201313). Besides causing infections, experimental studies in gno- tobiotic mice have revealed that enterococci play an"]}
{"query": "You receive the following question:\nQuestion: How does the design of the experiment using faeces from cytolysin\u2010negative patients aid in understanding the mechanism of phage treatment in this context?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: What specific phage treatments were administered in the chronic\u2013binge feeding model to target key bacterial populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT.\n", "relevant_passages": ["Hepatocytes were isolated from C57BL/6 female mice fed the chronic\u2013 binge ethanol diet (NIAAA model)15. Livers were perfused in situ with 0.5 mM EGTA containing calcium-free salt solution and then perfused with a solution containing 0.02% (w/v) collagenase D (Roche Applied Science). Livers were then carefully minced and filtered using a 70-\u03bcm nylon cell strainer. Hepatocytes were centrifuged at 50g for 1 min after 3 washes. Hepatocyte viability was assessed by Trypan Blue (Thermo Fisher"]}
{"query": "You receive the following question:\nQuestion: Which hepatic mRNAs are used as indicators of ethanol metabolism in the liver according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice.\n", "relevant_passages": ["Formalin-fixed tissue samples were embedded in paraffin and stained with H & E. To determine lipid accumulation, liver sections were embed- ded in OCT compound. Eight-micrometre frozen sections were then cut and stained with Oil Red O (Sigma-Aldrich). Representative images from each group of mice are shown in each figure. The terminal deoxynucleo- tide transferase-mediated dUTP nick-end labelling (TUNEL) assay was performed using an in situ cell death detection kit (Sigma-Aldrich). We randomly"]}
{"query": "You receive the following question:\nQuestion: What observation has been made in Atp4aSl/Sl mice regarding bacterial overgrowth?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: we investigated the effects of treatment with bacteriophages (here- after, phages). Phages are ubiquitous in bacteria-rich environments, including the gut16. E. faecalis phages that are highly strain-specific can be isolated17, which potentially makes the direct editing of gut microbiota feasible. It has previously been shown that Atp4aSl/Sl mice, which lack gastric acid, have overgrowth of intestinal enterococci, which is associated with increased susceptibility to alcohol-induced\n", "relevant_passages": ["testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Give P values as exact values whenever suitable. For Bayesian analysis, information on the choice of priors and Markov chain Monte Carlo settings For hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes Estimates of effect sizes (e.g. Cohen's d, Pearson's r), indicating how they were calculated"]}
{"query": "You receive the following question:\nQuestion: Which genetic components were highlighted in the study in relation to Enterococcus faecalis\u2019s pathogenic potential?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: pathogenicity islands and plasmids14. Detection of any other antimicrobial resistance genes or virulence genes in E. faecalis isolates did not correlate with disease severity or mortality in patients with alcoholic hepatitis (Supplementary Table 4).\n", "relevant_passages": ["To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of"]}
{"query": "You receive the following question:\nQuestion: Is there any evidence in the provided text linking lactose to bacterial expansion or alteration in the gastrointestinal tract?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: failure, such as gastrointestinal bleeding) (Supplementary Table 2). Infection was not associated with 30-day, 90-day or 180-day mortality (P = 0.403, 0.234 or 0.098) in patients with alcoholic hepatitis.\n", "relevant_passages": ["we investigated the effects of treatment with bacteriophages (here- after, phages). Phages are ubiquitous in bacteria-rich environments, including the gut16. E. faecalis phages that are highly strain-specific can be isolated17, which potentially makes the direct editing of gut microbiota feasible. It has previously been shown that Atp4aSl/Sl mice, which lack gastric acid, have overgrowth of intestinal enterococci, which is associated with increased susceptibility to alcohol-induced"]}
{"query": "You receive the following question:\nQuestion: How does an ethanol diet influence the gut barrier and the movement of E. faecalis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: non-cytolytic E. faecalis and fed an ethanol diet, but not when mice were fed an isocaloric (control) diet (Extended Data Fig. 2i); this indicates that ethanol-induced changes in the gut barrier are necessary for the translocation of cytolytic E. faecalis from the intestine to the liver. The livers of ethanol-fed mice that were given cytolytic or non-cytolytic E. faecalis had positive E. faecalis cultures (Extended Data Fig. 2j). We observed an increased intestinal permeability in ethanol-fed\n", "relevant_passages": ["this study plus 54 Enterococcus phage genomes obtained from Gen- Bank, with 5,000 12-mers generated per genome (mash sketch -k 12 -s 5000). The sketch file was then compared to all the initial phage genome sequences to generate the ANI matrix using the mash distance command using default settings. The GGRaSP R package was used to calculate the UPMGA phylogeny from the ANI distance matrix, after redundant phage genomes (genomes ANI >99.985) were removed using the GGRaSP R package with a user"]}
{"query": "You receive the following question:\nQuestion: Which test was applied specifically for survival analysis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: SNP site. P values are determined by permutational multivariate analysis of variance (PERMANOVA) followed by false discovery rate (FDR) procedures (a), two-sided Fisher\u2019s exact test followed by FDR procedures (b) or two-sided log- rank (Mantel\u2013Cox) test (c). The exact group size (n) and P values for each comparison are listed in Supplementary Table 10.\n", "relevant_passages": ["To extend our findings to humans, we colonized germ-free mice with faeces from cytolysin-positive and cytolysin-negative patients with alcoholic hepatitis (Supplementary Table 8). Consistent with our findings from mice colonized with cytolytic E. faecalis, gnotobi- otic C57BL/6 mice colonized with faeces from two cytolysin-positive patients developed more severe ethanol-induced liver injury, steatosis, inflammation and fibrosis than mice given faeces from two cytolysin- negative patients (Fig."]}
{"query": "You receive the following question:\nQuestion: How was the in vivo model used to study the microbiota composition related to patients with alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: What is the proposed therapeutic strategy for treating alcoholic hepatitis mentioned in the text?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: work is required to determine whether phages that target cyto- lytic E. faecalis might be used to treat patients with alcoholic hepatitis, a life-threatening disease that at present has no effective treatment. Eradication of this specific bacterial strain might produce better out- comes than current treatments, and environmental sources can be used to easily isolate phages that target cytolysin-positive E. faecalis. Here we provide an example of the efficacy of approaches based on phages in mice\n", "relevant_passages": ["important role in colitis (14) by stimulat- ing antigen-presenting cells and CD4+RORg+ T cell infiltration, causing intestinal inflam- mation (15). In this study, we investigated the role of enterococci in the development of acute GVHD, both in allo-HCT patients and preclinical allo-HCT mouse models."]}
{"query": "You receive the following question:\nQuestion: How effective is corticosteroid therapy for patients with severe alcoholic hepatitis as described in the content?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The most severe form of alcohol-related liver disease is alcoholic hepa- titis; mortality ranges from 20% to 40% at 1\u20136 months, and as many as 75% of patients die within 90 days of a diagnosis of severe alcoholic hepatitis7\u20139. Therapy with corticosteroids is only marginally effective9. Early liver transplantation is the only curative therapy, but is offered only at select centres and to a limited group of patients10.\n", "relevant_passages": ["The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive"]}
{"query": "You receive the following question:\nQuestion: What aspects of the disease are being investigated with respect to microbial influence?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: What unique characteristic does the E. faecalis strain isolated from the Atp4aSl/Sl mice possess?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: steatohepatitis11. The gavaging of wild-type mice with an E. faecalis strain isolated from Atp4aSl/Sl mice led to increased ethanol-induced steatohepatitis11. We found that this same E. faecalis strain expressed cytolysin. We then isolated four distinct phages from sewage water. These phages lyse the cytolytic E. faecalis strain isolated from Atp4aSl/Sl mice. All four phages were podophages of the virulent Picovirinae group (Extended Data Fig. 4). Atp4aSl/Sl mice and their wild-type littermates\n", "relevant_passages": ["Bacteriophage sequencing and phage tree: Albacore v2.3.4 (ONT), Porechop v0.2.3, Unicycler v0.4.7 pipeline, Pilon v1.22, CLC Genomics Workbench 4.9, NCBI Prokaryotic Genome Annotation Pipeline, in-house PERL script using Xfig, Phage_Finder, MASH program, GGRaSP and APE R-package, iTOL tree viewer 16S sequencing: MOTHUR-based 16S rDNA analysis workflow E. faecalis genome sequencing and tree: abricate v0.8.10 , Prokka, Roary, RAXML, iTOL Statistical analyses: R"]}
{"query": "You receive the following question:\nQuestion: How does gavaging with cytolytic E. faecalis affect liver inflammation and cytokine expression compared to the PBS control?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: How does the colonization of mice with E. faecalis affect the liver according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive\n", "relevant_passages": ["cytolytic E. faecalis to the liver after ethanol administration (Fig. 2g). The overall composition of the intestinal microbiota was not differ- ent between mice fed the control diet and colonized with faeces from cytolysin-positive or cytolysin-negative donors with alcoholic hepatitis, as shown by 16S rRNA gene sequencing. Mice transplanted with faeces from one of the cytolysin-positive patients with alcoholic hepatitis (patient no. 2) showed a microbiota that was significantly different from"]}
{"query": "You receive the following question:\nQuestion: How does gastric acid suppression affect the intestinal microbiota according to Llorente et al.?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 11. Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat. Commun. 8, 837 (2017).\n", "relevant_passages": ["and Parabacteroides diastonis; see materials and methods) (10, 18, 19) 21 days prior to allo-HCT (LP/J\u2192gnotobiotic C57BL/6). One group of mice was cocolonized on day \u221221 with E. faecalis OG1RF, which remained detectable in mouse feces on days 0 and +7 (Fig. 2D, right panel, and fig. S4E). GVHD was exacerbated in E. faecalis\u2013harboring mice"]}
{"query": "You receive the following question:\nQuestion: What specific components were used in the incubation experiments to assess hepatocyte survival?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: groups, right), and incubated with vehicle, CylLS\u2032\u2032, CylLL\u2032\u2032 or both of the cytolysin subunits at the indicated concentrations without (\u2013) or with (+) ethanol (25 mM) for 3 h. The survival of hepatocytes was determined in three independent experiments. Scale bar, 100 \u03bcm. Results are expressed as mean \u00b1 s.e.m. (a, b, d\u2013f, h). P values are determined by one-way analysis of variance (ANOVA) with Tukey\u2019s post hoc test (a, b, d\u2013f), two-sided Fisher\u2019s exact test followed by FDR procedures (g) or\n", "relevant_passages": ["Plus fragment library kit and sequenced using a 316 Chip on an Ion Torrent Personal Genome Machine (Life Technologies). Reads were trimmed according to modified Phred scores of 0.5 using CLC Genomics Workbench 4.9 (Cambridge), and the remaining reads were assembled using CLC Genomics Workbench 4.9 based on 98% identity with a minimum of 50% read overlap39. Reads were assembled into a single contig of 18,186 bp (20,118 \u00d7 coverage)."]}
{"query": "You receive the following question:\nQuestion: What information does the construction of a core genome SNP tree provide regarding the method of evaluating E. faecalis in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis whose faecal samples were cytolysin-positive (n = 25) or cytolysin-negative (n = 54) (P < 0.0001). d, Core genome single-nucleotide polymorphism (SNP) tree of E. faecalis strains isolated from patients with alcoholic hepatitis (n = 93 strains, from 24 patients), showing phylogenetic diversity of cytolysin-positive (red) E. faecalis. Genomically identical isolates from the same patient were combined, and are shown as a single dot. Scale bar represents the nucleotide substitutions per\n", "relevant_passages": ["of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice."]}
{"query": "You receive the following question:\nQuestion: What specific characteristic of E. faecalis determines the severity of alcoholic hepatitis according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Supplementary Tables 4\u20136). These results confirm our findings that the presence of cytolysin-producing E. faecalis rather than the total amount or presence of E. faecalis per se determines the severity of alcoholic hepatitis and mortality.\n", "relevant_passages": ["work is required to determine whether phages that target cyto- lytic E. faecalis might be used to treat patients with alcoholic hepatitis, a life-threatening disease that at present has no effective treatment. Eradication of this specific bacterial strain might produce better out- comes than current treatments, and environmental sources can be used to easily isolate phages that target cytolysin-positive E. faecalis. Here we provide an example of the efficacy of approaches based on phages in mice"]}
{"query": "You receive the following question:\nQuestion: What evidence supports the occurrence of bacterial translocation from the gut to the liver in ethanol-fed mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: non-cytolytic E. faecalis and fed an ethanol diet, but not when mice were fed an isocaloric (control) diet (Extended Data Fig. 2i); this indicates that ethanol-induced changes in the gut barrier are necessary for the translocation of cytolytic E. faecalis from the intestine to the liver. The livers of ethanol-fed mice that were given cytolytic or non-cytolytic E. faecalis had positive E. faecalis cultures (Extended Data Fig. 2j). We observed an increased intestinal permeability in ethanol-fed\n", "relevant_passages": ["this study plus 54 Enterococcus phage genomes obtained from Gen- Bank, with 5,000 12-mers generated per genome (mash sketch -k 12 -s 5000). The sketch file was then compared to all the initial phage genome sequences to generate the ANI matrix using the mash distance command using default settings. The GGRaSP R package was used to calculate the UPMGA phylogeny from the ANI distance matrix, after redundant phage genomes (genomes ANI >99.985) were removed using the GGRaSP R package with a user"]}
{"query": "You receive the following question:\nQuestion: What differences in liver pathology were observed when mice gavaged with non-cytolytic E. faecalis were fed ethanol?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: In comparison to widely-used models like MELD and ABIC, how does the predictive capability of cytolysin stand out for mortality prediction?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis. When we performed receiver-operating-characteristic curve analysis for 90-day mortality, cytolysin had an area under the curve of 0.81, which was superior to other widely used predictors for mortality in clinical practice (Extended Data Fig. 1e). On the basis of our findings, we propose that the detection of cytolysin may be a prognostic factor for more severe liver- related outcomes and increased risk of death, and a stronger predictor of mortality than MELD, ABIC and the\n", "relevant_passages": ["To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and"]}
{"query": "You receive the following question:\nQuestion: What evidence supports the role of cytolysin in influencing microbial dynamics that could drive disease processes?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes\n", "relevant_passages": ["followed by FDR procedures for multiple group comparisons. Jaccard dissimilarity matrices were used for PCoA, and P values were determined by PERMANOVA followed by FDR procedures to correct for multiple comparisons."]}
{"query": "You receive the following question:\nQuestion: What predictive biomarker has the study data identified for severe alcoholic hepatitis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: for a disease that is not considered a classic infectious disease. Our data also suggest that cytolysin may be used as a predictive biomarker of severe alcoholic hepatitis; an independent, prospective\n", "relevant_passages": ["We used 16S ribosomal RNA (rRNA) gene sequencing to study the fecal microbiota of 1325 adult allo-HCT recipients at four HCT centers: Memorial Sloan Kettering Cancer"]}
{"query": "You receive the following question:\nQuestion: What effect does cytolytic E. faecalis have on intestinal absorption in mice?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Administration of cytolytic or non-cytolytic E. faecalis to mice did not significantly change the composition of the intestinal microbiota, as shown by 16S rRNA gene sequencing (Extended Data Fig. 2l). Cytolytic E. faecalis did not affect intestinal absorption or hepatic metabolism\n", "relevant_passages": ["DNA from human stool samples, mouse liver sections or bacterial cul- ture was extracted as previously described11, and DNA from mouse faeces was extracted using QIAamp Fast DNA Stool kit (Qiagen). 16S rRNA PCR was completed using Illumina adaptor and barcode-ligated 16S primers targeting the V4 region of the 16S rRNA gene47,48. Amplicons were purified using the Qiaquick PCR purification kit (Qiagen) using manufacturer\u2019s specifications. Purified amplicons were then quantified via TECAN assay"]}
{"query": "You receive the following question:\nQuestion: What details about patient sample collection and clinical data are described in the text, and do they include any insights into microbiological components like lactose?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were recruited from an alcohol withdrawal unit in San Diego and Brussels, where they followed a detoxification and rehabilitation programme. At admission to the hospital, a complete medication and medical history was taken, and a complete physical examination was performed, including collection of bio-specimens, basic demographic data (such as age, gender, weight and height) and self-reported daily alcohol consumption. Patients were actively drink- ing until the day of admission. Controls or\n", "relevant_passages": ["expansion of enterococci. This process may be triggered through a loss of lactase produced by enterocytes damaged by conditioning or allo-reactive T cells. We validated this concept experimentally, by showing that depletion of lactose in vitro and in vivo inhibited enterococcal expan- sion and mitigated GVHD, and clinically, by showing that patients harboring a lactose- malabsorption allele experienced prolonged Enterococcus domination after antibiotic ex- posure. These observations in mice and"]}
{"query": "You receive the following question:\nQuestion: How does cytolysin positivity correlate with mortality outcomes in alcoholic hepatitis patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)\n", "relevant_passages": ["that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes"]}
{"query": "You receive the following question:\nQuestion: Which treatment is identified as the only curative option for severe alcoholic hepatitis, and what limitations does it have?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: The most severe form of alcohol-related liver disease is alcoholic hepa- titis; mortality ranges from 20% to 40% at 1\u20136 months, and as many as 75% of patients die within 90 days of a diagnosis of severe alcoholic hepatitis7\u20139. Therapy with corticosteroids is only marginally effective9. Early liver transplantation is the only curative therapy, but is offered only at select centres and to a limited group of patients10.\n", "relevant_passages": ["The colonization of mice with E. faecalis induces mild hepatic stea- tosis and exacerbates ethanol-induced liver disease11, by mechanisms that are unclear. Cytolysin is a bacterial exotoxin (or bacteriocin) that is produced by E. faecalis12, and which contains two post-translationally modified peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032) in its bioactive form6. The two peptides are encoded by two separate genes: cylLL and cylLS, respec- tively12. Cytolysin has lytic activity against not only Gram-positive"]}
{"query": "You receive the following question:\nQuestion: Which disease is identified in the study as being transmissible through the faecal microbiota?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: Which diagnostic procedure was utilized to confirm the presence of alcoholic hepatitis when it was clinically indicated?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: lack of signed informed consent. In all patients, the clinical picture was consistent with alcoholic hepatitis and in patients who underwent liver biopsy, the histology was consistent with the diagnosis of alco- holic hepatitis. Liver biopsies were only done if clinically indicated as part of routine clinical care for diagnostic purposes of alcoholic hepatitis. Bio-specimens were collected during their admission to the hospital. The median time of specimen collection was 4 days fol- lowing\n", "relevant_passages": ["Ferring Pharmaceuticals; is an inventor on patent application number WPO2015179437A1, entitled \u201cMethods and compositions for reducing Clostridium difficile infection,\u201d and patent number WPO2017091753A1, entitled \u201cMethods and compositions for reducing vancomycin-resistant Enterococci infection or colonization\u201d; and holds patents that receive royalties from Seres Therapeutics Inc. Other authors have no competing interests. Data and materials availability: All data are available in the manuscript"]}
{"query": "You receive the following question:\nQuestion: How does the analysis confirm that the effect of cytolysin is independent of other clinical factors?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic\n", "relevant_passages": ["Compared to Atp4aSl/Sl mice gavaged with control phages or vehicle, Atp4aSl/Sl mice gavaged with phages that target cytolytic E. faecalis had less severe liver injury, steatosis and inflammation after chronic ethanol feeding (Extended Data Fig. 5a\u2013f). Administration of E. faecalis phages significantly reduced levels of cytolysin in the liver (Extended Data Fig. 5g) as well as faecal amounts of Enterococcus (Extended Data Fig. 5h). Phage administration did not affect the overall composition of"]}
{"query": "You receive the following question:\nQuestion: What are the characteristics of the phage-based therapeutic agents described in the study, and how are they customized for individual patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: What distinct morphological characteristics were noted for the phages isolated against the cytolytic E. faecalis strains?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: Is there any discussion in the content regarding mechanisms that could be linked to graft\u2010versus\u2010host disease or the influence of specific nutrients like lactose on microbial populations?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were recruited from an alcohol withdrawal unit in San Diego and Brussels, where they followed a detoxification and rehabilitation programme. At admission to the hospital, a complete medication and medical history was taken, and a complete physical examination was performed, including collection of bio-specimens, basic demographic data (such as age, gender, weight and height) and self-reported daily alcohol consumption. Patients were actively drink- ing until the day of admission. Controls or\n", "relevant_passages": ["expansion of enterococci. This process may be triggered through a loss of lactase produced by enterocytes damaged by conditioning or allo-reactive T cells. We validated this concept experimentally, by showing that depletion of lactose in vitro and in vivo inhibited enterococcal expan- sion and mitigated GVHD, and clinically, by showing that patients harboring a lactose- malabsorption allele experienced prolonged Enterococcus domination after antibiotic ex- posure. These observations in mice and"]}
{"query": "You receive the following question:\nQuestion: Which pro-inflammatory mediator is reduced following the lytic phage treatment targeting cytolytic E. faecalis?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: How does the application of these lytic phages influence ethanol-induced liver injury and associated pathological markers?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: given three or four different\u2014but patient- specific\u2014lytic phages against cytolytic E. faecalis. The phages against cytolytic E. faecalis abolished ethanol-induced liver injury and steatosis, as shown by lower levels of ALT, lower percentages of hepatic cells positive for terminal deoxynucleotide transferase-mediated dUTP nick-end labelling, and lower levels of hepatic triglycerides and oil red O-staining (Fig. 3b\u2013d, Extended Data Fig. 7a, b), as well as by decreased hepatic levels of Il1b,\n", "relevant_passages": ["Patients with alcohol use disorder fulfilling the DSM IV criteria (J Abnorm Psychol. 1997;106:545-553) were recruited from an alcohol withdrawal unit in San Diego, USA and Brussels, Belgium where they followed a detoxification and rehabilitation program. Alcoholic hepatitis patients were enrolled from the InTeam Consortium (ClinicalTrials.gov identifier number: NCT02075918) from centers in the USA, Mexico, United Kingdom, France and Spain. Detailed inclusion and"]}
{"query": "You receive the following question:\nQuestion: How do the findings exclude ethanol metabolism differences as a factor in the observed microbial effects?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes\n", "relevant_passages": ["followed by FDR procedures for multiple group comparisons. Jaccard dissimilarity matrices were used for PCoA, and P values were determined by PERMANOVA followed by FDR procedures to correct for multiple comparisons."]}
{"query": "You receive the following question:\nQuestion: How does the experimental design differentiate between the control and targeted phage treatments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: chronic\u2013binge feeding model, gavaged with control phages against C. crescentus (1010 plaque-forming units (PFUs)) or a cocktail of three or four different phages that target cytolytic E. faecalis (1010 PFUs), 1 day before an ethanol binge. b, Serum levels of ALT.\n", "relevant_passages": ["Hepatocytes were isolated from C57BL/6 female mice fed the chronic\u2013 binge ethanol diet (NIAAA model)15. Livers were perfused in situ with 0.5 mM EGTA containing calcium-free salt solution and then perfused with a solution containing 0.02% (w/v) collagenase D (Roche Applied Science). Livers were then carefully minced and filtered using a 70-\u03bcm nylon cell strainer. Hepatocytes were centrifuged at 50g for 1 min after 3 washes. Hepatocyte viability was assessed by Trypan Blue (Thermo Fisher"]}
{"query": "You receive the following question:\nQuestion: Based on the provided content, what details are available regarding lactose's biochemical role in expanding Enterococcus populations in graft-versus-host disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: How did the treatment with lytic phages influence ethanol-induced liver disease in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: ethanol-induced liver disease compared with control phages (Fig. 4b\u2013g, Extended Data Fig. 9a\u2013h), despite the reduc- tion of faecal Enterococcus (Fig. 4h). Our findings indicate that treat- ment with lytic phages can selectively attenuate the ethanol-induced liver disease caused by cytolysin-positive E. faecalis in humanized mice.\n", "relevant_passages": ["exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease."]}
{"query": "You receive the following question:\nQuestion: Based on the paper, what is the mechanism by which bacteriophage application influences disease outcomes?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease\n", "relevant_passages": ["and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of"]}
{"query": "You receive the following question:\nQuestion: At what point during the hospital admission were bio-specimens collected from the patients?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: lack of signed informed consent. In all patients, the clinical picture was consistent with alcoholic hepatitis and in patients who underwent liver biopsy, the histology was consistent with the diagnosis of alco- holic hepatitis. Liver biopsies were only done if clinically indicated as part of routine clinical care for diagnostic purposes of alcoholic hepatitis. Bio-specimens were collected during their admission to the hospital. The median time of specimen collection was 4 days fol- lowing\n", "relevant_passages": ["Ferring Pharmaceuticals; is an inventor on patent application number WPO2015179437A1, entitled \u201cMethods and compositions for reducing Clostridium difficile infection,\u201d and patent number WPO2017091753A1, entitled \u201cMethods and compositions for reducing vancomycin-resistant Enterococci infection or colonization\u201d; and holds patents that receive royalties from Seres Therapeutics Inc. Other authors have no competing interests. Data and materials availability: All data are available in the manuscript"]}
{"query": "You receive the following question:\nQuestion: Which molecular markers were upregulated in mice showing heightened liver inflammation due to cytolytic E. faecalis exposure?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: were gavaged with cytolytic E. faecalis also had more liver inflamma- tion with higher expression levels of mRNAs that encode inflamma- tory cytokines and chemokines (Il1b, Cxcl1 and Cxcl2) (Extended Data Fig. 2d\u2013f), compared with mice given PBS. Mice that were fed ethanol after they were gavaged with non-cytolytic E. faecalis had significantly less ethanol-induced liver injury, steatosis and inflammation (Extended Data Fig. 2a\u2013f) and longer survival times (Extended Data Fig. 2g), as compared\n", "relevant_passages": ["Phage raw sequence reads and annotated genomes are available at NCBI under the following consecutive BioSample IDs (SAMN11089809\u2013 SAMN11089827). GenBank accession numbers include: Efmus1 (MK721195), Efmus2 (MK721197), Efmus3 (MK721185), Efmus4 (MK721193), Ef2.1 (MK693030), Ef2.2 (MK721189), Ef2.3 (MK721192), Ef5.1 (MK721199), Ef5.2 (MK721186), Ef5.3 (MK721200), Ef5.4 (MK721191), Ef6.1 (MK721187), Ef6.2 (MK721188), Ef6.3 (MK721196), Ef6.4 (MK721190), Ef7.1 (MK721194), Ef7.2 (MK721183), Ef7.3"]}
{"query": "You receive the following question:\nQuestion: What biochemical evidence supports the involvement of ethanol in liver pathology as described in the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: of ethanol, as indicated by serum levels of ethanol and hepatic levels of Adh1 and Cyp2e1 mRNAs (which encode the two primary enzymes that metabolize ethanol in the liver) (Extended Data Fig. 2m, n). These results indicate that E. faecalis that produce cytolysin promote ethanol- induced liver disease in mice.\n", "relevant_passages": ["Formalin-fixed tissue samples were embedded in paraffin and stained with H & E. To determine lipid accumulation, liver sections were embed- ded in OCT compound. Eight-micrometre frozen sections were then cut and stained with Oil Red O (Sigma-Aldrich). Representative images from each group of mice are shown in each figure. The terminal deoxynucleo- tide transferase-mediated dUTP nick-end labelling (TUNEL) assay was performed using an in situ cell death detection kit (Sigma-Aldrich). We randomly"]}
{"query": "You receive the following question:\nQuestion: What role did the ethanol-fed mouse model play in the experimental design regarding cytolysin\u2019s effect?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine the mechanism by which cytolysin increases liver dis- ease, we isolated hepatocytes from mice fed ethanol or control diets, and stimulated them with pure bioactive cytolysin peptides (CylLL\u2032\u2032 and CylLS\u2032\u2032)6. Incubation of the primary mouse hepatocytes with the two cytolysin subunits caused a dose-dependent increase in cell death compared to hepatocytes that were incubated with vehicle or with one subunit only (Fig. 2h). When we isolated hepatocytes from ethanol-fed mice and then\n", "relevant_passages": ["from GenBank (denoted by black letters) and 19 were from this study (4 phages against cytolysin-positive E. faecalis isolated from mice (shown in blue letters); 7 phages against cytolysin-positive E. faecalis isolated from patients with alcoholic hepatitis (shown in pink letters); and 8 phages against cytolysin- negative E. faecalis isolated from patients with alcoholic hepatitis (shown in green letters)) with Mash43 using a sketch size of s = 5000 and a k-mer size of k = 12 and GGRaSP59"]}
{"query": "You receive the following question:\nQuestion: Where can detailed information on group sizes and P values be found as mentioned in the text regarding the study's comparisons?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: two-way ANOVA with Tukey\u2019s post hoc test (h). All results were generated from at least three independent replicates. The exact group size (n) and P values for each comparison are listed in Supplementary Table 10. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.\n", "relevant_passages": ["Mapping of ONT reads to the hybrid assemblies was used to deter- mine the orientation and terminal ends of linear phage genomes, and reference genomes served as guides to orient circular phage genomes. Phage genome assemblies were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP)40,41."]}
{"query": "You receive the following question:\nQuestion: What microbial alteration is associated with alcoholic hepatitis as noted in the research data?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: with an altered composition of the faecal microbiota. Differences in faecal microbiota composition were noted in patients with alcohol-use disorder and alcoholic hepatitis, compared to subjects without alcohol- use disorder (controls) (Fig. 1a, Extended Data Fig. 1a, b, Supplementary Tables 1, 2). One substantial difference that we observed was an increase in the proportion of Enterococcus spp. in patients with alcoholic hepa- titis: in these patients, 5.59% of faecal bacteria were Enterococcus\n", "relevant_passages": ["90-day (P = 0.004) and with 180-day mortality (P = 0.001) (Supple- mentary Table 3), even after we adjusted for the geographical origin of the patient, antibiotic treatment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. We found no multicollinear- ity between the detection of faecal cytolysin-encoding genes and these cofactors (variance inflation factor < 1.6), which indicates that cytolysin is an independent predictor of mortality in patients with alcoholic"]}
{"query": "You receive the following question:\nQuestion: Which subset of E. faecalis is specifically targeted by the phage treatment described in the study, and how was this selectivity demonstrated?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: What genetic elements were targeted to identify cytolysin-positive samples in the study, and how were they detected?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)\n", "relevant_passages": ["that of the other mouse groups after ethanol administration (Extended Data Fig. 3f). Non-cytolytic E. faecalis was not detected in stool samples from donors with cytolytic E. faecalis (Extended Data Fig. 3g). We did not observe differences in intestinal absorp- tion or hepatic metabolism of ethanol between mice colonized with faeces from cytolysin-positive versus cytolysin-negative patients (Extended Data Fig. 3h, i). Together, these results provide further evi- dence that cytolysin promotes"]}
{"query": "You receive the following question:\nQuestion: What genetic element is implicated in mediating the variability of cytolysin production in E. faecalis, as per the research?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine phylogeny of E. faecalis in patients with alcoholic hepatitis, we performed targeted culturing from stool samples. Whole- genome sequencing of 93 E. faecalis isolates revealed a broad phylo- genetic diversity of cytolysin-positive E. faecalis from patients with alcoholic hepatitis (Fig. 1d), which indicates that cytolysin production is a variable trait among E. faecalis isolates and that cytolysin is car- ried in mobile genetic elements, which include both chromosomally encoded\n", "relevant_passages": ["Cxcl1, Cxcl2, Col1a1 and Acta2 mRNAs, and reduced hepatic levels of cylLS, as compared with mice given control phages (against C. crescentus) (Fig. 3e\u2013h, Extended Data Fig. 7c, d). Treatment with phages against cytolytic E. faecalis also reduced faecal amounts of Enterococcus (Extended Data Fig. 7e) without affecting the overall composition of the gut microbiota (Extended Data Fig. 7f). Intestinal absorption of ethanol and hepatic metabolism were similar in all groups (Extended Data Fig. 7g, h)."]}
{"query": "You receive the following question:\nQuestion: Which specific strain of Enterococcus is implicated in the observed liver disease, and how was it characterized?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: ethanol-induced liver disease compared with control phages (Fig. 4b\u2013g, Extended Data Fig. 9a\u2013h), despite the reduc- tion of faecal Enterococcus (Fig. 4h). Our findings indicate that treat- ment with lytic phages can selectively attenuate the ethanol-induced liver disease caused by cytolysin-positive E. faecalis in humanized mice.\n", "relevant_passages": ["exacerbates disease severity in gnotobiotic models. Enterococcus growth is dependent on the disaccharide lactose, and dietary lactose depletion attenuates Enterococcus outgrowth and reduces the severity of GVHD in mice. Allo-HCT patients carrying lactose-nonabsorber genotypes showed compromised clearance of postantibiotic Enterococcus domination. We report lactose as a common nutrient that drives expansion of a commensal bacterium that exacerbates an intestinal and systemic inflammatory disease."]}
{"query": "You receive the following question:\nQuestion: What experimental model was used to extend the microbiological findings to human-derived samples?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To extend our findings to humans, we colonized germ-free mice with faeces from cytolysin-positive and cytolysin-negative patients with alcoholic hepatitis (Supplementary Table 8). Consistent with our findings from mice colonized with cytolytic E. faecalis, gnotobi- otic C57BL/6 mice colonized with faeces from two cytolysin-positive patients developed more severe ethanol-induced liver injury, steatosis, inflammation and fibrosis than mice given faeces from two cytolysin- negative patients (Fig.\n", "relevant_passages": ["Results are expressed as mean \u00b1 s.e.m. (except when stated otherwise). Univariate and multivariate Cox regression analysis was used to detect associations of cytolysin with overall mortality. The multivariate model was adjusted for geographical origin of the patients, antibiotic treat- ment, platelet count, and creatinine, bilirubin and INR as components of the MELD score. Univariate logistic regression analysis of laboratory and clinical parameters associated with the detection of cytolysin and"]}
{"query": "You receive the following question:\nQuestion: Which intervention discussed in the study triggers a shift in microbial composition that contributes to liver pathology?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 11. Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat. Commun. 8, 837 (2017).\n", "relevant_passages": ["and Parabacteroides diastonis; see materials and methods) (10, 18, 19) 21 days prior to allo-HCT (LP/J\u2192gnotobiotic C57BL/6). One group of mice was cocolonized on day \u221221 with E. faecalis OG1RF, which remained detectable in mouse feces on days 0 and +7 (Fig. 2D, right panel, and fig. S4E). GVHD was exacerbated in E. faecalis\u2013harboring mice"]}
{"query": "You receive the following question:\nQuestion: From what source were the phages against non-cytolytic E. faecalis isolated, and what morphological characteristics did they exhibit?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To demonstrate that the effect of phage treatment occurs via the targeting of cytolysin-positive E. faecalis, rather than a reduction in cytolysin-negative E. faecalis, we colonized gnotobiotic mice with faeces from cytolysin-negative patients with alcoholic hepatitis (Sup- plementary Table 8). Phages against non-cytolytic E. faecalis from patients were isolated from sewage water; they had siphophage or podophage morphology (Fig. 4a, Extended Data Fig. 8). These phages did not reduce features of\n", "relevant_passages": ["Disruption of intestinal microbial communities appears to underlie many human illnesses, but the mechanisms that promote this dysbiosis and its adverse consequences are poorly understood. In patients who received allogeneic hematopoietic cell transplantation (allo-HCT), we describe a high incidence of enterococcal expansion, which was associated with graft-versus-host disease (GVHD) and mortality. We found that Enterococcus also expands in the mouse gastrointestinal tract after allo-HCT and"]}
{"query": "You receive the following question:\nQuestion: Which microbial elements are proposed as contributing to the progression of the disease according to the text?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: Alcohol-related liver disease can be transmitted via faecal micro- biota4. We investigated the microorganisms and microbial factors that are responsible for this transmissible phenotype and for progression of alcohol-related liver disease.\n", "relevant_passages": ["bacte- ria, but also eukaryotic cells13. We detected cylLL and cylLS genomic DNA (cytolysin-positive) in faecal samples from 30% of patients with alco- holic hepatitis; none of the faecal samples from controls and only one sample from a patient with alcohol-use disorder was cytolysin-positive, as detected by qPCR (Fig. 1b). Importantly, 89% of cytolysin-positive patients with alcoholic hepatitis died within 180 days of admission, compared to only 3.8% of cytolysin-negative patients (P < 0.0001)"]}
{"query": "You receive the following question:\nQuestion: What type of E. faecalis strains were cultured in this study and what was their clinical source?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and\n", "relevant_passages": ["Ethics oversight All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of the University of California, San Diego."]}
{"query": "You receive the following question:\nQuestion: How were experiments conducted with respect to randomization procedures?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment.\n", "relevant_passages": ["or T/T alleles) and malabsorption (C/C alleles) in the upper gut (29). Although abundance of the genus Enterococcus increased comparably during exposure to broad-spectrum antibiotics in both lactose absorbers and malabsorbers, enterococcal domination was significantly prolonged in malabsorbers after cessation of antibiotics (Fig. 4D and fig. S10). This finding suggests that the maintenance of enterococ- cal domination and microbiota recovery after broad-spectrum antibiotic exposure is signif-"]}
{"query": "You receive the following question:\nQuestion: Are there any studies or findings in the excerpt that address the role of bacterial metabolism, such as Enterococcus expansion, in mediating immune responses in disease settings like graft-versus-host disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: 7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012).\n", "relevant_passages": ["only recently became recognized as a major human pathogen; before the 1990s it was E. faecalis that caused >90% of clinical in- fections (17). Because E. faecalis expands in mice with GVHD and is the major Enterococcus species in laboratory mice, we next investigated whether E. faecalis contributes to GVHD. We colonized germ-free C57BL/6 mice with a com- munity of six bacterial strains (Akkermansia muciniphila, Lactobacillus johnsonii, Blautia producta, Bacteroides sartorii, Clostridium bolteae,"]}
{"query": "You receive the following question:\nQuestion: What experimental approach was used to determine the phylogeny of E. faecalis in patients with alcoholic hepatitis, and what did it reveal about cytolysin production?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine phylogeny of E. faecalis in patients with alcoholic hepatitis, we performed targeted culturing from stool samples. Whole- genome sequencing of 93 E. faecalis isolates revealed a broad phylo- genetic diversity of cytolysin-positive E. faecalis from patients with alcoholic hepatitis (Fig. 1d), which indicates that cytolysin production is a variable trait among E. faecalis isolates and that cytolysin is car- ried in mobile genetic elements, which include both chromosomally encoded\n", "relevant_passages": ["Cxcl1, Cxcl2, Col1a1 and Acta2 mRNAs, and reduced hepatic levels of cylLS, as compared with mice given control phages (against C. crescentus) (Fig. 3e\u2013h, Extended Data Fig. 7c, d). Treatment with phages against cytolytic E. faecalis also reduced faecal amounts of Enterococcus (Extended Data Fig. 7e) without affecting the overall composition of the gut microbiota (Extended Data Fig. 7f). Intestinal absorption of ethanol and hepatic metabolism were similar in all groups (Extended Data Fig. 7g, h)."]}
{"query": "You receive the following question:\nQuestion: How is cytolysin proposed to influence liver-related outcomes and the risk of death according to the study?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: hepatitis. When we performed receiver-operating-characteristic curve analysis for 90-day mortality, cytolysin had an area under the curve of 0.81, which was superior to other widely used predictors for mortality in clinical practice (Extended Data Fig. 1e). On the basis of our findings, we propose that the detection of cytolysin may be a prognostic factor for more severe liver- related outcomes and increased risk of death, and a stronger predictor of mortality than MELD, ABIC and the\n", "relevant_passages": ["To develop a therapeutic approach to precisely edit the intestinal microbiota, we cultured cytolytic E. faecalis strains from the faecal samples of patients with alcoholic hepatitis. We then isolated lytic phages from sewage water against these cytolytic E. faecalis strains; these phages had siphophage or myophage morphology (Fig. 3a, Extended Data Fig. 6). Gnotobiotic mice were colonized with faeces from two cytolysin-positive patients with alcoholic hepatitis (Sup- plementary Table 8) and"]}
{"query": "You receive the following question:\nQuestion: How do bacteriophages modify the levels of cytolysin in the liver, and what effect does this have in the mouse model?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: bacteriophages that target cytolytic E. faecalis. We found that these bacteriophages decrease cytolysin in the liver and abolish ethanol-induced liver disease in humanized mice. Our findings link cytolytic E. faecalis with more severe clinical outcomes and increased mortality in patients with alcoholic hepatitis. We show that bacteriophages can specifically target cytolytic E. faecalis, which provides a method for precisely editing the intestinal microbiota. A clinical trial with a larger cohort\n", "relevant_passages": ["hepatitis whose faecal samples were cytolysin-positive (n = 25) or cytolysin-negative (n = 54) (P < 0.0001). d, Core genome single-nucleotide polymorphism (SNP) tree of E. faecalis strains isolated from patients with alcoholic hepatitis (n = 93 strains, from 24 patients), showing phylogenetic diversity of cytolysin-positive (red) E. faecalis. Genomically identical isolates from the same patient were combined, and are shown as a single dot. Scale bar represents the nucleotide substitutions per"]}
{"query": "You receive the following question:\nQuestion: How does the cytolytic E. faecalis strain (FA2-2(pAM714)) influence liver injury in ethanol-fed mice relative to control treatments?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: To determine whether cytolysin contributes to liver damage mediated by E. faecalis, we gavaged mice with a cytolytic E. faecalis strain (FA2- 2(pAM714)) or a non-cytolytic E. faecalis strain (FA2-2(pAM771))5; the mice were then placed on a chronic\u2013binge ethanol diet15. Compared to mice gavaged with phosphate-buffered saline (PBS), mice fed with ethanol after they were gavaged with cytolytic E. faecalis developed more severe liver injury as indicated by a higher level of alanine amino-\n", "relevant_passages": ["7. Maddrey, W. C. et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193\u2013199 (1978).\n\n8. Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am. J. Gastroenterol. 103, 2747\u20132756 (2008).\n\n9. Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med. 372, 1619\u20131628 (2015).\n\n10. Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol. 56, S39\u2013S45 (2012)."]}
{"query": "You receive the following question:\nQuestion: How is the disease described in terms of its classification as an infectious disease?\nThis is about the following piece of text from a microbiology paper:\nPaper Title: Lactose drives Enterococcus expansion to promote graft-versus-host disease\nPaper chunk: for a disease that is not considered a classic infectious disease. Our data also suggest that cytolysin may be used as a predictive biomarker of severe alcoholic hepatitis; an independent, prospective\n", "relevant_passages": ["We used 16S ribosomal RNA (rRNA) gene sequencing to study the fecal microbiota of 1325 adult allo-HCT recipients at four HCT centers: Memorial Sloan Kettering Cancer"]}
>>>>>>> 5b6e3e1f6bb904635df1f05e870b8aeeed94cf1b
